Furthermore, ROC curve analysis demonstrated that the protein levels of ECM1 and ANXA1 in uEVs could effectively differentiate between breast cancer patients and healthy controls or patients with benign breast nodules (Figures 4D, E; Table 2). This evidence concerns the gene ECM1 and breast carcinoma.